<bill session="108" type="s" number="892" updated="2023-01-15T23:33:09Z">
  <state datetime="2003-04-11">REFERRED</state>
  <status>
    <introduced datetime="2003-04-11"/>
  </status>
  <introduced datetime="2003-04-11"/>
  <titles>
    <title type="display">Prescription Drug Fairness for Seniors Act of 2003</title>
    <title type="official" as="introduced">A bill to provide for substantial reductions in the price of prescription drugs for medicare beneficiaries.</title>
    <title type="short" as="introduced">Prescription Drug Fairness for Seniors Act of 2003</title>
  </titles>
  <sponsor bioguide_id="J000177"/>
  <cosponsors/>
  <actions>
    <action datetime="2003-04-11">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2003-04-11" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSFI" name="Senate Finance" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Ambulatory care"/>
    <term name="Canada"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="East Asia"/>
    <term name="Europe"/>
    <term name="Foreign Trade and International Finance"/>
    <term name="France"/>
    <term name="Germany"/>
    <term name="Government Operations and Politics"/>
    <term name="Government contractors"/>
    <term name="Italy"/>
    <term name="Japan"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Social Welfare"/>
    <term name="Terminal care"/>
    <term name="Terminally ill"/>
    <term name="United Kingdom"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in Senate">Prescription Drug Fairness for Seniors Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price no greater than the manufacturer's average foreign price. Sets forth special provisions with respect to hospice programs.</summary>
</bill>
